國立虎尾科技大學 |

Medullary Thyroid Carcinoma = Biology – Management – Treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Medullary Thyroid Carcinoma/ edited by Friedhelm Raue.
其他題名:	Biology – Management – Treatment /
其他作者:	Raue, Friedhelm.
面頁冊數:	VIII, 249 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-22542-5
ISBN:	9783319225425

Medullary Thyroid Carcinoma = Biology – Management – Treatment /
Medullary Thyroid CarcinomaBiology – Management – Treatment /[electronic resource] :edited by Friedhelm Raue. - 1st ed. 2015. - VIII, 249 p.online resource. - Recent Results in Cancer Research,2040080-0015 ;. - Recent Results in Cancer Research,200.

Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.

This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.

ISBN: 9783319225425

Standard No.: 10.1007/978-3-319-22542-5doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Medullary Thyroid Carcinoma = Biology – Management – Treatment /
LDR:03271nam a22004095i 4500 001 968468
003 DE-He213
005 20200706080428.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319225425 $9 978-3-319-22542-5
024 7 $a 10.1007/978-3-319-22542-5 $2 doi
035 $a 978-3-319-22542-5
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Medullary Thyroid Carcinoma $h [electronic resource] : $b Biology – Management – Treatment / $c edited by Friedhelm Raue.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a VIII, 249 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Recent Results in Cancer Research, $x 0080-0015 ; $v 204
505 0 $a Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
520 $a This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.
650 0 $a Oncology . $3 1253469
650 0 $a Endocrinology . $3 1254221
650 0 $a Human genetics. $3 596505
650 0 $a Nuclear medicine. $3 673902
650 1 4 $a Oncology. $3 593951
650 2 4 $a Endocrinology. $3 645497
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Nuclear Medicine. $3 673045
700 1 $a Raue, Friedhelm. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1070091
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319225418
776 0 8 $i Printed edition: $z 9783319225432
776 0 8 $i Printed edition: $z 9783319362601
830 0 $a Recent Results in Cancer Research, $x 0080-0015 ; $v 200 $3 1263334
856 4 0 $u https://doi.org/10.1007/978-3-319-22542-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)